- Home
- CNTX vs SFWL Comparison
CNTX vs SFWL Comparison
Compare CNTX & SFWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNTX
- SFWL
- Stock Information
- Founded
- CNTX 2015
- SFWL 2001
- Country
- CNTX United States
- SFWL China
- Employees
- CNTX N/A
- SFWL N/A
- Industry
- CNTX Biotechnology: Pharmaceutical Preparations
- SFWL Trucking Freight/Courier Services
- Sector
- CNTX Health Care
- SFWL Industrials
- Exchange
- CNTX Nasdaq
- SFWL Nasdaq
- Market Cap
- CNTX 75.6M
- SFWL 82.3M
- IPO Year
- CNTX 2021
- SFWL 2023
- Fundamental
- Price
- CNTX $0.82
- SFWL $1.04
- Analyst Decision
- CNTX Strong Buy
- SFWL
- Analyst Count
- CNTX 5
- SFWL 0
- Target Price
- CNTX $5.25
- SFWL N/A
- AVG Volume (30 Days)
- CNTX 162.2K
- SFWL 23.3K
- Earning Date
- CNTX 11-05-2025
- SFWL 08-27-2025
- Dividend Yield
- CNTX N/A
- SFWL N/A
- EPS Growth
- CNTX N/A
- SFWL 31.68
- EPS
- CNTX N/A
- SFWL 0.14
- Revenue
- CNTX N/A
- SFWL $540,461,000.00
- Revenue This Year
- CNTX N/A
- SFWL N/A
- Revenue Next Year
- CNTX N/A
- SFWL N/A
- P/E Ratio
- CNTX N/A
- SFWL $7.40
- Revenue Growth
- CNTX N/A
- SFWL 21.10
- 52 Week Low
- CNTX $0.49
- SFWL $0.86
- 52 Week High
- CNTX $2.59
- SFWL $1.60
- Technical
- Relative Strength Index (RSI)
- CNTX 52.03
- SFWL 49.67
- Support Level
- CNTX $0.81
- SFWL $1.00
- Resistance Level
- CNTX $0.94
- SFWL $1.14
- Average True Range (ATR)
- CNTX 0.05
- SFWL 0.08
- MACD
- CNTX -0.01
- SFWL -0.00
- Stochastic Oscillator
- CNTX 10.36
- SFWL 13.79
About CNTX Context Therapeutics Inc.
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.
About SFWL Shengfeng Development Limited
Shengfeng Development Ltd is a holding company. Through its subsidiaries, it offers contract logistics services in China. The contract logistics services offered by the company include planning and designing supply chains, designing facilities, processing orders, collecting payments, managing inventories, and providing client services.